Concepedia

Michael Wenger

MW

Statistics

Publications

51

Citations

6.9K

H-Index

30

Active since

1993

Affiliations

Roche (Switzerland)(Current)

Universität Ulm

University Hospital Cologne

University of Cologne

Roche (United Kingdom)

Michael Wenger is an author at Roche (Switzerland) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1993–2019

51

Publications

51

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

Valentin Goede, Kirsten Fischer, Raymonde Busch et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Robert Marcus, Andrew Davies, Kiyoshi Ando et al. · New England Journal of Medicine · 2017 · 764 citations · Full text

Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial

Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka et al. · Blood · 2014 · 502 citations

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

Tadeusz Robak, Anna Dmoszyńska, Philippe Solal‐Céligny et al. · Journal of Clinical Oncology · 2010 · 475 citations

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

Sebastian Böttcher, Matthias Ritgen, Kirsten Fischer et al. · Journal of Clinical Oncology · 2012 · 445 citations

1–5 of 51